Form 4: QuidelOrtho Director Edward L. Michael Trades Shares
Insider Transaction Report
Director Edward L. Michael of QuidelOrtho Corp (QDEL) reported a transaction involving the release of restricted stock units on June 6, 2026.
Summary
- Director Edward L. Michael reported the release of restricted stock units (RSUs) on June 6, 2026.
- A total of 963 RSUs were released, resulting in the acquisition of 963 shares of common stock.
- Additionally, 289 premium RSUs were released, resulting in the acquisition of 289 shares of common stock.
- These releases were part of a deferred compensation program for non-employee directors and followed an elected deferred schedule.
- Following these transactions, Mr. Michael beneficially owns 29,144 shares directly and 29,433 shares directly after the premium RSU release.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity compensation vesting and release by a director, which is a standard procedural event and does not indicate new financial performance or strategic shifts.
Positives
- Director Edward L. Michael's RSUs vested and were released, indicating the fulfillment of prior compensation awards.
- The transactions were executed according to a pre-established deferred compensation program and elected schedule, suggesting adherence to corporate governance policies.
Negatives
- The filing details the release of previously granted equity, which is a standard compensation event and not indicative of new positive performance.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it pertains to past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, common across the biotechnology and diagnostics industry, and this filing by a director of QuidelOrtho Corp (QDEL) is typical for reporting equity compensation vesting and release.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Deferred Compensation Program | The release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors. | Not specified, but the program was in effect for the June 6, 2026 transaction. | Demonstrates adherence to established compensation policies and provides directors with flexibility in managing their equity compensation. |
Stakeholder Impact
- Shareholders: The release of RSUs represents the fulfillment of compensation obligations to a director and does not inherently change beneficial ownership in a way that would immediately impact share price, but it does confirm the director's continued equity stake.
Key Dates
| Date | Description |
|---|---|
| 06/06/2026 | Transaction Date for the release of restricted stock units. |
| 06/09/2026 | Date of the signature on the Form 4 filing. |
Keywords
QuidelOrtho Corp, QDEL, Form 4, SEC Filing, Director, Restricted Stock Units, RSU Release, Deferred Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.